EP Patent

EP1186293A2 — Intermittent administration of a growth hormone secretagogue

Assigned to Pfizer Products Inc · Expires 2002-03-13 · 24y expired

What this patent protects

The present invention relates to the intermittent administration of a growth hormone secretagogue to a patient and to kits for use therein.

USPTO Abstract

The present invention relates to the intermittent administration of a growth hormone secretagogue to a patient and to kits for use therein.

Drugs covered by this patent

Patent Metadata

Patent number: EP1186293A2
Jurisdiction: EP
Classification: —
Expires: 2002-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Products Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.